Clinical Trial Update: Study of Single and Multiple Doses of ALS-008176 in Healthy Volunteers [Phase 1]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 1 study evaluating single and multiple doses of the RSV antiviral ALS-008176 in healthy volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• ALS-008176

Snippet

Sponsor: Alios Biopharma Inc. | Conditions: Respiratory Syncytial Virus Infections | Phase 1 | Status: COMPLETED